Emergent BioSolutions Inc.(EBS)
Biopharmaceutical company that produces Narcan, a naloxone nasal spray for opioid overdose reversal.
2 Insights
Investment Insights
AI-generated insights about Emergent BioSolutions Inc. from various financial sources
Thursday, October 16, 2025
Bearish
Factual news: An insider sold shares worth $306,080, which can be a bearish signal.
Tuesday, August 12, 2025
Very Bullish
The spread of highly potent nitazines is expected to drive significant and sustained demand for overdose reversal drugs like Narcan, potentially expanding the market to Europe.
Thursday, October 16, 2025
Bearish
Factual news: An insider sold shares worth $306,080, which can be a bearish signal.
Tuesday, August 12, 2025
Very Bullish
The spread of highly potent nitazines is expected to drive significant and sustained demand for overdose reversal drugs like Narcan, potentially expanding the market to Europe.